Sign in to follow
Search Results

0 results for 'Valeant Pharmaceuticals International Inc'

You can use to get even better search results
April 06, 2015 |

Skadden Runs Up Against Davis Polk, S&C for Lead in M&A Rankings

After dominating the top spot in three separate M&A rankings of legal advisers by deal value last year, Skadden, Arps, Slate, Meagher & Flom was bumped by Davis Polk & Wardwell and Sullivan & Cromwell in two of the rankings for the first quarter.
3 minute read
April 06, 2015 | Law.com

Skadden Runs Up Against Davis Polk, S&C for Lead in M&A Rankings

After dominating the top spot in three separate M&A rankings of legal advisers by deal value last year, Skadden, Arps, Slate, Meagher & Flom was bumped by Davis Polk & Wardwell and Sullivan & Cromwell in two of the rankings for the first quarter.
3 minute read
April 02, 2015 |

Contact Lens Makers Face Price-Fixing Class Action

A putative class action suit filed in federal court in Newark accuses four manufacturers and a distributor of disposable contact lenses of conspiring to eliminate price competition by entering into illegal resale price maintenance agreements with retailers.
3 minute read
March 30, 2015 |

2015 Dealmakers of the Year

Our Dealmakers of the Year package is no rote examination of the 2014's biggest transactions. Instead, we spotlight creative thinking, novel approaches and innovative work. Here we present 20 transactions—some big, some small—where effective lawyering truly made the difference.
4 minute read
March 30, 2015 | Law.com

2015 Dealmakers of the Year

Our Dealmakers of the Year package is no rote examination of the 2014's biggest transactions. Instead, we spotlight creative thinking, novel approaches and innovative work. Here we present 20 transactions—some big, some small—where effective lawyering truly made the difference.
4 minute read
March 19, 2015 |

Deal Watch: One Skadden Client Ousts Another in Duel for Salix

Our latest roundup of transactions sees Skadden client Valeant Pharmaceuticals International prevail over fellow firm client Endo International in its bid for Salix Pharmaceuticals, while Latham & Watkins, Ropes & Gray and Simpson Thacher & Bartlett advise several private equity clients on their proposed acquisitions of Chicago's Willis Tower and Life Time Fitness.
3 minute read
March 19, 2015 | Law.com

Deal Watch: One Skadden Client Ousts Another in Duel for Salix

Our latest roundup of transactions sees Skadden client Valeant Pharmaceuticals International prevail over fellow firm client Endo International in its bid for Salix Pharmaceuticals, while Latham & Watkins, Ropes & Gray and Simpson Thacher & Bartlett advise several private equity clients on their proposed acquisitions of Chicago's Willis Tower and Life Time Fitness.
3 minute read
March 13, 2015 |

The Am Law 100, the Early Numbers: Elite New York Firms Once Again Break From the Pack

The top New York-centered firms outperformed their rivals in 2014. Revenue grew an average of 4.5 percent at 17 top firms based in the Big Apple, while profits per partner rose 5.6 percent, according to reporting by The American Lawyer.
13 minute read
March 12, 2015 |

Deal Watch: Skadden Advising Endo and Valeant, With Both Vying for Salix

Our latest roundup of transactions sees Sullivan & Cromwell, Skadden, Freshfields and Davis Polk take the lead for companies in the analytics, entertainment and pharmaceutical sectors.
5 minute read
March 12, 2015 | Law.com

Deal Watch: Skadden Advising Endo and Valeant, With Both Vying for Salix

Our latest roundup of transactions sees Sullivan & Cromwell, Skadden, Freshfields and Davis Polk take the lead for companies in the analytics, entertainment and pharmaceutical sectors.
5 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources